Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 3
2019 5
2020 6
2021 7
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
S2k-Leitlinie Hilfsmittelberatung.
Butea-Bocu M, Foller S, Gleisner J, Kahlmeyer A, Karstedt H, Kirschner-Hermanns R, Liebald T, Linne C, Manseck A, Moll V, Otto U, Piotrowski A, Schorn A, Stein J, Wagner A, Wiedemann A; Als Mandatsträger weiterer Fachgesellschaften: Dt. Gesellschaft für Geriatrie: Dr. Klaus Becher; Dt. Gesellschaft für Gynäkologie und Geburtshilfe: Prof. Dr. Christl Reisenauer; Dt. Kontinenz Gesellschaft e. V.: Prof. Dr. Daniela Schultz-Lampel; GKV-Spitzenverband: Dr. Christine Kuhlmann; Dt. Gesellschaft für Pflegewissenschaften: Dr. Daniela Hayder-Beichel; Inkontinenz Selbsthilfe e. V.: Mathias Zeisberger. Butea-Bocu M, et al. Aktuelle Urol. 2021 Apr;52(2):168-180. doi: 10.1055/a-1293-2831. Epub 2021 Apr 1. Aktuelle Urol. 2021. PMID: 33822346 German. No abstract available.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
INTERPRETATION: Switching to riociguat from PDE5i treatment, both of which act via the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate pathway, could be a strategic option for treatment escalation in patients with PAH at intermediate risk of 1-year mortality …
INTERPRETATION: Switching to riociguat from PDE5i treatment, both of which act via the nitric oxide-soluble guanylate cyclase-cyclic guanosi …
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. Parish SJ, et al. J Womens Health (Larchmt). 2021 Apr;30(4):474-491. doi: 10.1089/jwh.2021.29037. Epub 2021 Apr 1. J Womens Health (Larchmt). 2021. PMID: 33797277 Free PMC article.
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.
Dreyling M, Santoro A, Mollica L, Leppä S, Follows GA, Lenz G, Kim WS, Nagler A, Panayiotidis P, Demeter J, Özcan M, Kosinova M, Bouabdallah K, Morschhauser F, Stevens DA, Trevarthen D, Giurescu M, Cupit L, Liu L, Köchert K, Seidel H, Peña C, Yin S, Hiemeyer F, Garcia-Vargas J, Childs BH, Zinzani PL. Dreyling M, et al. J Clin Oncol. 2017 Dec 10;35(35):3898-3905. doi: 10.1200/JCO.2017.75.4648. Epub 2017 Oct 4. J Clin Oncol. 2017. PMID: 28976790 Clinical Trial.
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Park DH, Ewert R, Kaemmerer H, Kabitz HJ, Skowasch D, Behr J, Milger K, Halank M, Wilkens H, Seyfarth HJ, Held M, Dumitrescu D, Tsangaris I, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Lange TJ, Rosenkranz S. Hoeper MM, et al. Eur Respir J. 2022 Jul 7;60(1):2102311. doi: 10.1183/13993003.02311-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34737226 Free PMC article.
Long-term adherence and response to botulinum toxin in different indications.
Lee JI, Jansen A, Samadzadeh S, Kahlen U, Moll M, Ringelstein M, Soncin G, Bigalke H, Aktas O, Moldovan AS, Waskoenig J, Jander S, Gliem M, Schnitzler A, Hartung HP, Hefter H, Albrecht P. Lee JI, et al. Ann Clin Transl Neurol. 2021 Jan;8(1):15-28. doi: 10.1002/acn3.51225. Epub 2020 Dec 1. Ann Clin Transl Neurol. 2021. PMID: 33259153 Free PMC article.
Risk assessment in pulmonary arterial hypertension.
Hoeper MM, Pittrow D, Opitz C, Gibbs JSR, Rosenkranz S, Grünig E, Olsson KM, Huscher D. Hoeper MM, et al. Eur Respir J. 2018 Mar 29;51(3):1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29599117 Free article. No abstract available.
28 results